中医药治疗Luminal型乳腺癌的特色探析
Discussion on the Features of Traditional Chinese Medicine Treating Luminal Type Breast Cancer
-
摘要: 现代医学认为乳腺癌是一个慢性全身性疾病,其中Luminal型乳腺癌占乳腺癌总数的50%以上,该类患者在接受规范内分泌治疗的同时又面临着不良反应多、依从性差、易产生耐药及远期复发转移等几大难点,针对这些难点,可以通过中医药对其进行干预治疗,且有众多的临床研究和实验研究结果均证明了中医药在防治内分泌治疗的不良反应、改善药物耐药、提高患者依从性及降低远期复发转移风险多个方面有显著疗效。Abstract: Modern medicine considers breast cancer to be a chronic systemic disease, of which luminal type breast cancer accounts for over 50% of the total cases of breast cancer. While given standardized endocrine therapy, patients with this kind of disease suffered from major side effects such as adverse reactions, poor compliance, tending to drug resistance and long-term recurrence and metastasis. In response to these difficulties, it can be intervened and treated by traditional Chinese medicine. Numerous clinical studies and experimental research results have shown that traditional Chinese medicine has significant effects on the prevention of multiple adverse reactions caused by endocrine therapy, including improving drug resistance, enhancing patients' compliance and reducing long-term recurrence and metastasis risk.
-
[1] 张少华,江泽飞.2011年St.Gallen国际乳腺癌治疗专家共识相关问题解读[J].中国实用外科杂志,2011,31(10):918-919. [2] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2017年版)[J].中国癌症杂志,2017,27(9):695-759. [3] 柏尚柱.乳腺癌在中国的流行状况和疾病特征[J].世界最新医学信息文摘,2017,17(41):253-256. [4] IHEMELANDU CU,LEFFALL LD,DEWITTY RL,et al.Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specie prevalence and survival[J].J Surg Res,2007,143(1):109-118. [5] HENRY NL,AZZOUZ F,DESTA Z,et al.Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer[J]. J Clin Oncol,2012,30(9):936-942. [6] WULANINGSIH W,GARMO H,AHLGREN J,et al.Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity[J].Breast Cancer Res Treat,2018,172(1):167-177. [7] BARRON TI,CONNOLLY R,BENNETT K,et al.Early discontinuation of tamoxifen: a lesson for oncologists[J].Cancer,2007,109(5):832-839. [8] MCCOWAN C,SHEARER J,DONNAN PT,et al.Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer[J].Brit J Cancer,2008,99(11):1763-1768. [9] MURSGROVE EA,SUTHERLAND RL.Biological determinants of resistance in breast cancer[J].Nat Rev Cancer,2009,9(9):631-643. [10] JOHNSTON SR. New strategies in estrogen receptor-positive breast cancer[J].Clin Cancer Res,2010,16(7):1979-1987. [11] 尹碧蓉,罗泊涛,陆元志.乳腺癌内分泌治疗耐药机制的研究进展[J].重庆医学,2017,46(31):4429-4432. [12] 贾岩,佟仲生.乳腺癌内分泌治疗耐药机制的研究进展[J].中国肿瘤临床,2019,46(4):204-207. [13] COLLEONI M, SUN Z, PRICE KN, et al. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials Ⅰ to Ⅴ[J]. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 2016,34(9):927-935. [14] Early Breast Cancer Trialists Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomised trials[J].Lancet, 2005,365(9472):1687-1717. [15] 卞卫和,李琳,张晓清,等.疏肝调阴阳方改善乳腺癌术后他莫昔芬不适症状群与提高生活质量的临床研究[J].南京中医药大学学报,2013,29(6):529-531. [16] 王旺胜,尤建良,薛青.益肾沉潜方治疗乳腺癌内分泌期他莫昔芬副作用疗效观察[J].山西中医,2017,33(7):23-25. [17] 郭鹏,江淑滢,朱为康.凉血疏肝方改善他莫昔芬致乳腺癌患者子宫内膜增厚的临床研究[J].现代医药卫生,2018,34(3):401-403. [18] 殷玉莲,张卫红,周悦,等.补肾壮骨方防治芳香化酶抑制剂引起的骨代谢异常的临床研究[J].中国骨质疏松杂志,2018,24(9):1195-1200. [19] 李元青,孙红,薛冬,等.舒肝健骨方防治芳香化酶抑制剂内分泌治疗相关骨丢失的临床研究[J].中国中西医结合杂志,2014,34(9):1064-1068. [20] 吕晓皑,王蓓,叶荆.补肾活血方治疗乳腺癌芳香化酶抑制剂所致骨丢失疗效观察[J].浙江中西医结合杂志,2014,24(8):684-685. [21] 张晓清,任晓梅,卞卫和,等.杞菊地黄丸加减治疗早期乳腺癌术后服用芳香化酶抑制剂致高血脂症的临床研究[J].现代中西医结合杂志,2018,27(35):3912-3915. [22] 王志超,鲍双振,杨进强,等.阿托伐他汀联合活血降浊汤对绝经后乳腺癌经内分泌治疗患者血脂、心血管事件及骨密度的影响[J].现代中西医结合杂志,2019,28(8):826-829,835. [23] 陈绪,许岩磊,应语,等.三黄煎剂降低ROS促进乳腺癌他莫昔芬耐药细胞凋亡的实验研究[J].吉林中医药,2016,36(5):504-509. [24] 陆清,薛晓红.“乳癌术后方”拮抗乳腺癌三苯氧胺治疗耐药的体外实验研究[J].江苏中医药,2018,50(1):79-82. [25] 张俊杰.益气温阳方对乳腺癌内分泌治疗患者无病生存期及生活质量的影响[J].社区医学杂志,2015,13(13):48-50. [26] 周雍明,崔峰,李军.中药方对乳腺癌内分泌治疗患者生命质量影响的临床研究[J].世界中医药,2018,13(5):1131-1133. [27] 张剑辉,杨婧,刘颖,等.健脾益肾颗粒对乳腺癌内分泌治疗患者无病生存期及生活质量的影响[J].中医药导报,2016,22(11):33-34,39. [28] 林毅,陈前军,刘鹏熙.乳腺癌分期辨证规范化——一个中医乳房病学与时俱进的重要课题[J].中西医结合学报,2006,4(5):447-450. [29] 陈前军,司徒红林,官卓娅.林毅教授“分期辨证”治疗可手术乳腺癌经验[J].辽宁中医药大学学报,2011,13(4):11-13.
点击查看大图
计量
- 文章访问数: 604
- HTML全文浏览量: 19
- PDF下载量: 544
- 被引次数: 0